No Data
Jiangsu Favored Nanotechnology's (SHSE:688371) Returns On Capital Not Reflecting Well On The Business
The transfer price for the shareholders of Feivate has been initially set, with a discount of 14.68% compared to the market price, and 8 institutional investors are participating in the acquisition.
① Investment banking professionals at institutions indicate that the shareholding method of inquiry transfer is an innovation in the design of the star system at that time, which can help mitigate the impact of shareholding reduction; ② Analysts from private equity state that the sector of electronic components in which the company operates has seen a price increase exceeding that of Fevolite's stock prices since the beginning of the year. With the company's stock price being at a relatively low position, discounting the inquiry transfer of shares is relatively objective and reasonable.
Feiwo Tai (688371.SH): has cumulatively repurchased 1.3857% of the shares.
On December 2, GeLongHui announced that as of November 30, 2024, the company's second phase of share repurchases through the Shanghai Stock Exchange trading system in the form of centralized bidding trading has accumulated a repurchase of 4,648,538 shares, accounting for 1.3857% of the company's total share capital of 335,472,356 shares. The highest price at which the repurchase was transacted was 17.73 yuan per share, and the lowest price was 8.61 yuan per share, with a total amount paid of RMB 50,055,341.18 (excluding stamp duty, transaction commission, and other transaction fees).
We Think Shareholders Should Be Aware Of Some Factors Beyond Jiangsu Favored Nanotechnology's (SHSE:688371) Profit
Jiangsu Favored Nanotechnology Co., Ltd's (SHSE:688371) 31% Jump Shows Its Popularity With Investors
Fivotai: Jiangsu Fivotai Nanotechnology Co., Ltd. Report for the third quarter of 2024
After Leaping 26% Jiangsu Favored Nanotechnology Co., Ltd (SHSE:688371) Shares Are Not Flying Under The Radar
